CVS Health Corp. - S&P Global Ratings’ Credit Research

CVS Health Corp.

CVS Health Corp. - S&P Global Ratings’ Credit Research
CVS Health Corp.
Published Nov 25, 2025
17 pages (6769 words) — Published Nov 25, 2025
Price US$ 500.00  |  Buy this Report Now

About This Report

  
Abstract:

This report does not constitute a rating action. Overview Key strengths Key risks Significant scale and presence in U.S. health care market. Litigation can arise from unexpected sources with large potential liabilities. Solid segment diversification across health insurance, pharmacy benefits, pharmacy, and front-of-store. Legislation or regulation could disrupt business model, particularly in insurance and PBM. Top market positions held by its largest businesses Aetna, CVS Pharmacy, and Caremark. Credit metrics currently at weaker end for the rating. Sizable free cash flow at a low point of nearly $5 billion. with solid visibility into improvement in the health care benefits segment. CVS has partially completed a multiyear improvement of its health care benefits segment in which it is prioritizing margins, particularly

  
Brief Excerpt:

...We expect CVS Health Corp.'s adjusted debt to EBITDA to improve below 4x in 2026, with solid visibility into improvement in the health care benefits segment. CVS has partially completed a multiyear improvement of its health care benefits segment in which it is prioritizing margins, particularly in Medicare Advantage plans. In this market, CVS has refined its plan offerings and benefits to improve profitability, although we think it will take several more years for profitability to reach target levels. CVS also received improved star quality ratings from the Centers for...

  
Report Type:

Full Report

Ticker
Issuer
GICS
Health Care Services (35102015)
Sector
Global Issuers , Public Finance , Structured Finance
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "CVS Health Corp." Nov 25, 2025. Alacra Store. Nov 07, 2026. <http://www.alacrastore.com/s-and-p-credit-research/CVS-Health-Corp-3485995>
  
APA:
S&P Global Ratings’ Credit Research. (). CVS Health Corp. Nov 25, 2025. New York, NY: Alacra Store. Retrieved Nov 07, 2026 from <http://www.alacrastore.com/s-and-p-credit-research/CVS-Health-Corp-3485995>
  
US$ 500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Residential Mortgage-Backed Securities from one place.